Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-26 @ 2:24 AM
Study NCT ID:
NCT05068102
Status:
RECRUITING
Last Update Posted:
2025-10-15
First Post:
2021-09-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-03
Start Date Type:
ACTUAL
Primary Completion Date:
2026-04-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-19
First Submit QC Date:
None
Study First Post Date:
2021-10-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-13
Last Update Post Date:
2025-10-15
Last Update Post Date Type:
ESTIMATED